Trial intelligence / Profile preview

Ketodex efficacy for adult procedural sedation

IRCT20130108012072N13Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketamine + dexmedetomidine, sponsored by Isfahan University of Medical Sciences. Started Sep 2022; status: completed.

02

Drugs

ketamine + dexmedetomidine

Beyond the preview

Go deeper on IRCT20130108012072N13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130108012072N13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call